• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Azenta Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    12/10/25 12:45:25 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology
    Get the next $AZTA alert in real time by email
    azta20251209_8k.htm
    false 0000933974 0000933974 2025-12-09 2025-12-09
     


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
    PURSUANT TO SECTION 13 or 15(d) OF
    THE SECURITIES EXCHANGE ACT OF 1934
     
    Date of Report (Date of earliest event reported): December 9, 2025
     
    Azenta, Inc.
    (Exact name of registrant as specified in its charter)
     
    Delaware
     
    0-25434
     
    04-3040660
    (State or Other Jurisdiction
    of Incorporation)
     
    (Commission File
    Number)
     
    (IRS Employer
    Identification No.)
     
    200 Summit Drive, 6th Floor, Burlington, MA 01803
    (Address of principal executive offices and Zip Code)
     
    (888) 229-3682
    (Registrant’s telephone number, including area code)
     
    N/A
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
     
    Trading Symbol(s)
     
    Name of each exchange on which registered
    Common Stock, $0.01 par value
     
    AZTA
     
    The Nasdaq Stock Market LLC
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company  ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
     


     
     

     
     
    Item 7.01. Regulation FD Disclosure.
     
    On December 10, 2025, Azenta, Inc. (“Azenta” or the “Company”) issued a press release announcing the Repurchase Program (as defined below), a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8‑K. In addition, as previously announced on October 15, 2025, Azenta will hold an Investor Day beginning at 1:00 p.m. ET on December 10, 2025. A copy of the presentation that will be used in connection with the Investor Day is attached hereto as Exhibit 99.2.
     
    The information furnished in this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.
     
    Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the presentation attached as Exhibit 99.2 hereto, the presentation contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the presentation regarding these forward-looking statements.
     
     
    Item 8.01. Other Events.
     
    On December 8, 2025, the Board of Directors (the “Board”) of Azenta authorized a stock repurchase program (the “Repurchase Program”), under which the Company may repurchase up to $250 million of its outstanding common stock. The Repurchase Program is intended to enhance shareholder value and capitalize on undervaluation. The Repurchase Program became effective on December 9, 2025 and is scheduled to expire on December 31, 2028, unless extended, suspended or terminated earlier by the Board.
     
    Repurchases under the Repurchase Program may be made from time to time in the open market, in privately negotiated transactions, in accelerated share repurchases, through block trades, or through trading plans intended to qualify under Rule 10b5‑1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in each case, subject to market conditions and applicable legal and regulatory requirements, including Rule 10b‑18 under the Exchange Act. The timing, volume and price of repurchases will be determined at the discretion of the Company’s management based on a variety of factors, including stock price, general business and market conditions, alternative investment opportunities, liquidity, and other considerations.
     
    The Repurchase Program does not obligate the Company to acquire any particular amount of common stock, and it may be modified, suspended or terminated at any time without prior notice. Repurchases under the Repurchase Program are expected to be funded using the Company’s available cash reserves, operating cash flow, or other sources as determined by management, consistent with the Company’s financial policies.
     
     
    Item 9.01. Financial Statements and Exhibits.
     
    (d) Exhibits
     
    Exhibit No.
    Description
     
    99.1
    Press release dated December 10, 2025.
    99.2
    Azenta, Inc. Investor Day Presentation dated December 10, 2025.
    104
    Cover Page Interactive Data File (embedded within Inline XBRL document).
     
     

     
     
    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    AZENTA, INC.
       
     
    /s/ Ephraim Starr
    Date: December 10, 2025
    Ephraim Starr
     
    Senior Vice President, General Counsel and Secretary
     
     
    Get the next $AZTA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZTA

    DatePrice TargetRatingAnalyst
    10/30/2025$38.00Hold → Buy
    Jefferies
    8/6/2025$35.00Mkt Perform → Outperform
    Raymond James
    7/22/2025$35.00Equal-Weight
    Stephens
    12/18/2024$50.00 → $60.00Equal-Weight → Overweight
    Stephens
    4/4/2024$64.00Hold
    Jefferies
    2/1/2024$61.00 → $79.00Buy
    B. Riley Securities
    7/19/2023Mkt Perform
    Raymond James
    5/10/2023Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $AZTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4/A filed by Azenta Inc.

    4/A - Azenta, Inc. (0000933974) (Issuer)

    12/3/25 6:29:19 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    President and CEO Marotta John was granted 122,269 units of Common, increasing direct ownership by 129% to 217,269 units (SEC Form 4)

    4 - Azenta, Inc. (0000933974) (Issuer)

    11/25/25 8:26:42 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    EVP, CFO and Treasurer Lin Lawrence Y. was granted 36,681 units of Common, increasing direct ownership by 85% to 79,655 units (SEC Form 4)

    4 - Azenta, Inc. (0000933974) (Issuer)

    11/25/25 8:23:14 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    $AZTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Azenta Authorizes $250 Million Share Repurchase Program

    BURLINGTON, Mass., Dec. 10, 2025 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase up to $250 million of its outstanding common stock. The Repurchase Program is intended to enhance shareholder value and capitalize on undervaluation. Repurchases may be made from time to time through open market repurchases, privately negotiated transactions, or by other methods compliant with Rules 10b-18 and 10b5-1 of the Securities Exchange Act of 1934, subject to market and business conditions, applicable legal requirements, and other factors. This authorization does not obligate Azenta to re

    12/10/25 12:43:00 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

    Q4'25 reported revenue growth of 6% year over year and 4% on an organic basisFY'25 reported revenue growth of 4% and 3% on an organic basisFY'25 Adjusted EBITDA margin expansion of 310 basis points versus last yearFY'26 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis pointsBURLINGTON, Mass., Nov. 21, 2025 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2025. Quarter Ended Year Ended Dollars in millions, except per share data September 30, September 30, September 30, September 30, 2025 2024(1) Change 2025 2024(1) Change Revenue

    11/21/25 6:30:00 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast

    BURLINGTON, Mass., Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21, 2025, before the market opens. The Company will host a conference call and live webcast to discuss its financial results on the same day, Friday, November 21, 2025, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on November 22, 2025. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solut

    11/12/25 4:05:00 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    $AZTA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Azenta upgraded by Jefferies with a new price target

    Jefferies upgraded Azenta from Hold to Buy and set a new price target of $38.00

    10/30/25 7:56:09 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Azenta upgraded by Raymond James with a new price target

    Raymond James upgraded Azenta from Mkt Perform to Outperform and set a new price target of $35.00

    8/6/25 7:48:53 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Stephens resumed coverage on Azenta with a new price target

    Stephens resumed coverage of Azenta with a rating of Equal-Weight and set a new price target of $35.00

    7/22/25 7:51:21 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    $AZTA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Cornog William L bought $189,884 worth of Common (7,000 units at $27.13), increasing direct ownership by 37% to 25,795 units (SEC Form 4)

    4/A - Azenta, Inc. (0000933974) (Issuer)

    11/25/25 4:28:43 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Amendment: Director Malus Alan J bought $319,800 worth of Common (12,000 units at $26.65), increasing direct ownership by 238% to 17,035 units (SEC Form 4)

    4/A - Azenta, Inc. (0000933974) (Issuer)

    11/14/25 4:10:07 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Amendment: President and CEO Marotta John bought $25,990 worth of Common (1,000 units at $25.99), increasing direct ownership by 0.94% to 107,296 units (SEC Form 4)

    4/A - Azenta, Inc. (0000933974) (Issuer)

    11/14/25 4:10:08 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    $AZTA
    SEC Filings

    View All

    Azenta Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Azenta, Inc. (0000933974) (Filer)

    12/10/25 12:45:25 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    SEC Form 10-K filed by Azenta Inc.

    10-K - Azenta, Inc. (0000933974) (Filer)

    12/4/25 5:25:51 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    SEC Form NT 10-K filed by Azenta Inc.

    NT 10-K - Azenta, Inc. (0000933974) (Filer)

    12/2/25 5:18:18 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    $AZTA
    Leadership Updates

    Live Leadership Updates

    View All

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value

    William L. Cornog, Quentin Koffey and Alan J. Malus Add Deep Industry Expertise and Track Records of Shareholder Value Creation to the Board Establishes Value Creation Committee of the Board Comprised of New Directors, CEO John Marotta, and Current Director Martin Madaus Reaffirms Full-Year 2024 Financial Guidance BURLINGTON, Mass., Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) ("Azenta" or "the Company"), today announced the appointment of three new independent directors to its Board. William Cornog, former head of KKR Capstone, the portfolio operations team of KKR & Co., and Alan Malus, former Corporate Executive Vice President of Thermo Fisher, join as part of Azenta's ongoing i

    11/4/24 8:00:00 AM ET
    $AZTA
    $BV
    $LVWR
    Industrial Machinery/Components
    Technology
    Real Estate
    Motor Vehicles

    AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO

    Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass., Sept. 4, 2024 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth and successful transition.  Mr. Marotta has two decades of experience leading global companies in life sciences, medical devices, and diagnostics, and is joining Azenta from Patient Square Capital, a leading healthcare investment firm, where he serves as Executive in Residence. P

    9/4/24 8:00:00 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    $AZTA
    Financials

    Live finance-specific insights

    View All

    Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

    Q4'25 reported revenue growth of 6% year over year and 4% on an organic basisFY'25 reported revenue growth of 4% and 3% on an organic basisFY'25 Adjusted EBITDA margin expansion of 310 basis points versus last yearFY'26 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis pointsBURLINGTON, Mass., Nov. 21, 2025 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2025. Quarter Ended Year Ended Dollars in millions, except per share data September 30, September 30, September 30, September 30, 2025 2024(1) Change 2025 2024(1) Change Revenue

    11/21/25 6:30:00 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast

    BURLINGTON, Mass., Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21, 2025, before the market opens. The Company will host a conference call and live webcast to discuss its financial results on the same day, Friday, November 21, 2025, at 8:30 a.m. Eastern Time. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on November 22, 2025. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solut

    11/12/25 4:05:00 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance

    BURLINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2025. The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company's announcement in the first fiscal quarter of 2025 of its intention to pursue a sale. Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change 2025 2025 2024 Prior Qtr Prior Yr. Revenue from Continuing Operations $ 144 $ 143 $ 144 0 % (0) % Organic growth (2) % Sample Management Solutions $ 78 $ 80 $ 81 (3) % (4) % Multiomics $ 66 $ 64 $ 64 4 % 4 % Diluted EPS Continuing Operations

    8/5/25 6:30:00 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    $AZTA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Azenta Inc.

    SC 13G/A - Azenta, Inc. (0000933974) (Subject)

    11/13/24 4:05:02 PM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SC 13D/A filed by Azenta Inc.

    SC 13D/A - Azenta, Inc. (0000933974) (Subject)

    11/4/24 8:41:47 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G filed by Azenta Inc.

    SC 13G - Azenta, Inc. (0000933974) (Subject)

    10/31/24 11:55:02 AM ET
    $AZTA
    Industrial Machinery/Components
    Technology